The literature supports many different therapies used in recalcitrant pyoderma gangrenosum, which suggests that the pathophysiology is not yet understood. Our hypothesis is that certain patient demographic factors, including age or size of ulcer at presentation, may predict a poor clinical outcome.
Objective:
The goal of our study was to stimulate an analysis of pyoderma gangrenosum treatment failures to identify predisposing conditions that would increase the likelihood of failure.
Conclusion:
Patients older than 50 years of age or with an ulcer greater than 25 cm in diameter may have a poor outcome, but a systematic review of pyoderma gangrenosum treatment failures should be undertaken to support this hypothesis.
Get full access to this article
View all access options for this article.
References
1.
De ImusGGolombCWilkelC. Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression. J Am Acad Dermatol2001; 44:61–66.
2.
WeenigRHDavisMDPDahlPR. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med2002; 347:1412–1418.
3.
NghiemPPearsonGLangleyRG. Tacrolimus and pimecrolimus: From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol2002; 46:228–241.
4.
ReichKVenteCNeumannC. Topical tacrolimus For pyoderma gangrenosum. Br J Dermatol1998; 139:755–757.
5.
D'IncaRFagiuoliSSturnioloGC. Tacrolimus to treat pyoderma gangrenosum resistant to cyclosporin. Ann Intern Med1998; 1289:783–784.
6.
WeichertGSauderDN. Efficacy of tacrolimus (FK 506) in idiopathic treatment-resistant pyoderma gangrenosum. J Am Acad Dermatol1998; 38(4 Pt 1):648–650.
JollesSNiclasseSBensonE. Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosum. Br J Dermatol1999; 140:564–565.
9.
Richter-HintzDSchuppeHCHomeyB. Topical tacrolimus is effective in the treatment of pyoderma gangrenosum. J Am Acad Dermatol2000; 42(2 Pt 1):304–305.
10.
NousariHCLynchWAnhaltGJ. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum. Arch Dermatol1998; 134:1509–1511.
11.
GilmourEStewartDG. Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with cyclosporin and complicated by a mononeuritis. Br J Dermatol2001; 144:397–400.
